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Is dilution of cows' milk formula necessary for 
dietary management of acute diarrhoea in infants 
aged less than 6 months? 
M. C. LOPES J. A. C. MOTA O. FONTAINE 
F. CKEW F. J. E h W A  L. A. PERET FILHO C. QUAN 
There is concern that feeding full-strength animal 
milk to infants aged less than 6 months with 
diarrhoea may have adverse consequences. We 
assessed the effects on clinical course of two feeding 
regimens in 159 Guatemalan and Brazilian infants 
aged 2 weeks to 6 months who had had acute 
diarrhoea for 120 h or less, showed signs of mild to 
moderate dehydration, and had no complications. 
After correction of dehydration, infants were 
assigned randomly to receive continued full-strength 
milk feeding or initial feeding with diluted milk with 
regrading to full-strength milk over 48 h. There were 
no significant differences between feeding groups in 
rate of treatment failures (-1%. 95% CI -14 to 
12%) or mean (SD) total stool output (full-strength 
milk 335 [268] g/kg, diluted milk 338 [354] g/kg) 
and duration of diarrhoea (92 [50] vs 92 [U] h). 
A significant association was found between 
presence of reducing substances in stools and 
treatment failure (OR 4.3, 95% CI 1.1 to 16.8), but 
reducing substances in stools were common both in 
treatment successes (61 %) and in failures (87%). 
Our study supports the conclusion that, for infants 
under 6 months of age with diarrhoea whose only 
food is animal milk or formula, the milk or formula 
normally given should be provided in full strength as 
soon as dehydration has been corrected. 
Lancet 1993; 341 : 194-97. 
Introduction 
Correct early feeding during diarrhoea can prevent 
weight loss with no increased risk of "plications or 
severity.la However, there has been cí" that terrain 
foods, notably animal milk, may af€m adversely the dinical 
alurse of This apprehension has been largely 
relieved by studies showing that infants and children who 
normally take solid foods can safely take full-strength milk 
fonnula during diarrhoea, pmvided that it is given with such 
solid foods, usually cereals.su 
For infima whose sole nument is animal milk or formula, 
feeding during diarrhoea has remained problematic. 
Gmcun about the risks, in parricuiar lactose intolerance, 
assodatedwithfeedingsuchinfanafull-stengthanknalmilk 
or formda has.I& to recommendations that they be given 
reduced amounts of milk, either by diluting their usual milk 
formula and gradually regrading the intake over several days 
or by temporarily replacing milk formula with s p e d  
lactose-free or milk-kee formulae until diarrhoea  stop^.'^." 
These approaches, are, however, unsuitable for developing 
wunmes, where diarrhoea is a major cause of early 
childhood mortality and an important conmibutor to 
malnumuon. Reducing milk intake when it is the infant's 
only food carries a j s k  of weight loss and of deterioration in 
numtional status; it may also encourage mothers to continue 
giving diluted milk after diarrhoea stops. In addition, special 
formulae are prohibitively expensive. In these 
circumstances, the continued intake of íü&strength animal 
milk or formula would be highly advantageous for 
numtional and economic reasons. 
came to 
the conclusion that roudne dilution of milk formula had no 
beneficial effect on the clinid course of illness. However, 
both of these studies were conducted in the UK, where 
diarrhoea is usually mild in infant under 6 months old and 
they are well fed," and the results cannot be assumed to 
apply also to infants in developing wunmes who are 
frequently undernourished and in whom diarrhoea is often 
severe. We felt therefore that it was important to bercer 
define the risks associated with dilution of milk formula in 
developing countries. We present the results of a 
collaborative, randomised feeding trial in milk-fed infants 
aged less than 6 months with diarrhoea. Two dietary 
regimens were compared: continued full-strengch milk 
formula and initial feeding of diluted milk formula with 
regrading to full strength over 48 h. A lactose-free or 
millr-free formula was not studied because such formulae 
are not affordable for most families in the study populations. 
Two studies in infants aged less than 6 
Subjects and methods 
The study was c o n d u d  at rhe Metabolic Unir of the Instituto 
de Nuaidon de Cenm, America y Panama (MCAP), Guatemala, 
and at the Hospital das Clinicas of the Univmidade Fed& de 
Minas Gerais, Belo Horizonre, Brazil. The protocol was approved 
by'thc cthics "ittees of both insdtutions and of the World 
Health Organuation. Patients admitted to the study were boys aged 
15 days 10 6 months with acute diarrhoea (defined as three or more 
watay stools in the previous 24 h), no visible blood in rhe stool, and 
no dinid signs of severe dehydration. Only patients who had had 
diarrhoea for less than lu) h bdore consultation were enrolled. 
Infànts were cxdudai if they had were malnutrition (wnpht for 
age <60% of the National Gum for Health Statistics 50th 
paccntilc'.), were exclusively or mostly breast-fed (infants who 
rcuived most of their energy from breast d), or had spremic 
idecrions or other diseass -specific additional aeaments. 
Informed omsent was obmned from the parent or guardian of 
cvay infant 
Patients who had clinical signs of dehydration on admission were 
rehydrated d y  m 4 to 6 h with the standard WHO/UNICEF 
g lua~cbaxd  oral rehydration salts (ORS) solution before the start 
of rhc study. Afta rehydration and until diarrhoea stopped, ORS 
solution and plain warn were o f f a d  according to WHO 
~ ~~ ~~ ~ 
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Rot& (Oh) 
Far (%) 
Carbohydrate (%) 
Energ  NI 
Energy from protein (%) 
Energy from fat (%) 
Energy from carbohydrate (%) 
Osmolarity (mOmol) 
TABLE I-COMPOSITION OF THE FULL-STRENGTH COWS' MILK 
FORMULAE (PER 100 M L  RECONSTITUTED FORMULA) 
Brazil 
1.65 
3.40 
7.40 
280 
295 
9.8 
45.7 
41.2 
Guatemala 
1 .M 
3.39 
6.90 
260 
290 
8.9 
49.2 
41.2 
recommendations for maintenance therapy. Feeding was started as 
won as infants were considered to be fully rehydrated. They were 
then assigned randomly to one of two feeding regimens: NI- 
suengih milk formula (group A), or progressive r e inducnon  of 
full-suengrh milk formula olalf-strength for the first 24 h, 
two-thirds suengrh for the second 24 h, and full-suength 
thereafter) (group B). One randomisation list per centre was 
established at WHO, Geneva, with random permuted blocks of 
variable lengrh (6 to 12 subjens per block). Individual patient 
assignments, corresponding to the master randomisation lists, were 
then p l a d  in sealed serially numbered envelopes and sent to the 
cenue. Milk formulae were prepared by a dietitian who was not 
otherwise involved in clinical management of patients or colleaion 
of clinical data. The different foxmulae, which were similar in 
appearance, were administered through opaque feeding bodes; 
sraffand investigaron did not know which formula was being given. 
The mamnument compositions of milk formulae used by each 
centre in the srudy are shown in table I; both formulae conrained 
appropriate amouncs of vitamins and minerals. Infants were offered 
150 mL/kg per day of milk, divided into eight feedings of equal 
volume. 
For each infant, faecal and urine output, volumes of ORS 
solution, water, and milk consumed, the dinical evaluation, number 
and charaneristics of stools passed, and &e number of vomiring 
episodes werc m r d e d  continuously and summarised for 8 h 
periods from the beginning of the study und the cessadon of 
diarrhoea, or for a maximum of 5 days, or und withdrawal from the 
study. Body weight was m r d e d  at the end of evcry 8 h. Patients 
were regarded as ucaunmt Mures when there was: r"e of 
dinical s i p  of dehydration during maintenance oral rehydration 
therapy; or weight loss of more than 5% of admission body waght, 
without dinical s i p  of dehydration, susained over two 
consecutive 24 h periods, or a 50% inntaSe m fäccal wight for 
consecutive 8 h periods whm the faecal waght in the prcvious 8 h 
TABLE II-CHARACTERISTICS OF PATIENTS ON ADMISSION 
B Y  DIETARY GROUP 
Characteristic 
Age 
Mean (SDI months 
Numbcr<3mo 
Number > 3 m o  
Mean (SO) weight (kg) 
Mean (SO) weight for age 
Median (/OR) duration of diarrhot 
Median (IQR) stools passedin 
No of patients who vomited in 
Hydration status on admission (no 
(2-scores) 
before admission (h) 
previous 24 h 
previous 24 h 
No signs of dehydrarim 
Sane dchydrnb  
S C v ~ r r  ,dehydradm 
Feeding panern on admission 
íno [%I) 
B m r - f a  
Diluted milk formula 
solids 
@.? IOR-interquanile range. ,.- 
Full-strength 
milk (n = BO) 
3.8 (1.6) 
23 
57 
5.1 (1.3) 
- 1.44 (- 1.12) 
72 (46 m 82) 
8.5 (6.5 to 105 
57 
54 
26 
O 
Diluted milk 
(n=79) 
3.6 (2.0) 
5.0 (1.3) 
19 
60 
- 1.39 (- 1.14) 
72 (30 m %) 
8.0 (5.0 m 10.0) 
46 
53 
26 
O 
was less than 50 g/kg; or a 25% increase in faecal weight over two 
consecutive 8 h periods when the faecal weight in the previous 8 h 
was more than 50 g/kg. Treatment failures were removed from rhe 
study and their feed was changed to a soya-based formula. 
On admission, a stool sample was taken to idennfy rotavirus by 
enzyme-linked immunosorbent assay (Dakopam A/S, Glosrmp, 
Denmark). Reducing substances in the stool were tested by 
Clinitat ( A m e s ) 1 9  on admission and on every altemate stool. The 
pH of every stool was measured with pH paper. 
The srudy was designed to detea a 20% difference berween 
ueament groups in [oral faecal output. We caldared that 68 
patients per group would have to be enrolled in the study to show 
this difference with a power of 80% and a signikance of 5v0.~ This 
calculation was based on an investigation showing that the mean 
(SD) total stool output of patients with diarrhoea in the study age 
group was 284 (111) g/kg (A. H. Madkour, personal 
communication). 
Statistical analyses were done with SPSS PC+ software. 
A two-tailed Student's t test was done for comparisons berween 
measures. Condnuous variables ,with skewed disaibution were 
normalised by log ransformation, ahd a two-tailed r test was applied 
to transformed data." Qualirative variables were compared wirh the 
xl test. 
Results 
From April, 1989, to June, 1991, 159 patients were 
enrolled in the study-71 at the Hospital das Clinicas and 88 
at the Metabolic Unit of INCAP. 80 patients were assigned 
randomly to receive full-snength milk formula and 79 to 
receive diluted milk formula. 143 patients were eligible for 
analysis: 2 patients (1 in each ueatment group and 1 at  each 
cenue) were excluded shody after treatment had begun 
when informed consent was withdrawn, and 14 patients (7 
in each neaunent p u p )  were removed from the study 
because of severe i n f h o n  requiring antibiotic mannent 
(bronchopneumonia [ll], urinary-tract infection [I], 
measles [l], sepsis [l]). The characteristics of the two 
neaunent groups on admission to the study were 
comparable (table II), and the admission characteristics of 
patients who were withdrawn from analysis were similar to 
t h q  of patients who were included in the final analysis 
(data not shown). 
Of the 143 eligible patients, 115 were regarded as 
neannent successes since they did nor fulfil any of the 
criteria for treaunent failure dcfíned above (table III). For 
101 of those patients, diarrhoea stopped within the 5-day 
study period; 14 patients (7 in each treatment group) still 
had diarrhoea after day 5. Of 10 of these patients seen daily 
after discharge, 9 ceased to have diarrhoea within 5 days 
without further medical intervention. 1 patient had 
diarrhoea for more than 14 days; his diet was changed to a 
lactose-frrc foxmula after discharge and he was also treated 
for an urinary-tract infection. The other 4 patients were lost 
to follow-up. 28 patients (20%) were considered to be 
ueatment failures (table III). The difference between 
treatment-failure rares in the two groups was not significant 
TABLE III-CLINICAL OUTCOME AFTER REINTRODUCTION 
OF MILK FEEDS 
Full-strength 
Clinical outcome milk (n=80) 
Treatment succe.ues 
Diarrhom stoppCd wirhin 5 days 51 171) 
Dianfi- aadnucd beyond day 5 7 (101 
Rsurrcnt ddlydmd" 
In& srcol outputt 8 (111 
Treatment failuras 
Diluted milk 
fn=791 
Number of patients (%) are shown. 
'Traaled with inumenous fluids: *sated by change in diel. 
I 
. I I  . . z. 
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Full-strengrh 
milk 
Stool output ar 24 h ( g k g )  98 (68) 
T o d  stool output (gjkg) 335 (268) 
T o d  stools passed 36(22) 
T o d  ORS intake (mLlkg) 238 (212) 
Tod milk formula intake 
& J k )  1318 (900) 
Diarrhoea duradon (h) 92 (50) 
Weight gain at discharge (%) 
- (n=72) 
0.8 (4.7) 
Diluted 
milk 
( n = 7 1 )  - 
77 (55) 1.3 (0.9, 1.8). 
338 (354) 1.1 (0+3,1.5)' 
39(26) -3(-11,5)t 
227 (291) 1.1 (0.7, 1.7)' 
1351 (971) -8 (-83,67)t 
92 (44) 1.0 (0.7, 1.3)' 
0.3 (4.4) 1.0 (0.6, 1,7)* 
( -  1 %, 95% CI - 14 to 12%). After inclusion as neaunent 
failures of the 14 patients who were removed from the study 
beause of severe infection, there was no difference between 
ueatment-failure rates (-0.3%, 95% CI - 14% to 13%). 
Data collected for all 143 patients, up to the time of their 
withdrawal from the study or their discharge from the 
hospital on day 5, were included in the final analysis (table 
IV). There were no significant differences between 
treament groups in the main outcome variables, including 
total stool output. However, m m  (SD) energy 
consumption during the first 24 h was significantly higher in 
the group that received full-strength milk formula (310 
[I301 vs 172 [67] kJ/kg; p<O.O5). Dmtion of diarrhoea, 
taking into account only patients whose diarrhoea stopped 
wirhin the 5-&y study period, did not differ between 
treatment groups. weight gain was similar in infants 
succffsfully neated with either diluted or full-strength milk 
formula. However, among treatment failures, weight gain 
was better for the group given full-suengrh milk (2.2% vs 
Stool reducing substances were measured for 74 patients, 
of whom 23 were treatment failures. There was no 
significant associaD'on between presene of reducing 
substances in stools and treannmt p u p .  On the other 
hand, a significant assodation was found b e e n  presena 
of reducing substances in the stools and ueaunent failures 
(OR 4.3, 95% CI 1.1 to 16.8). H o w ~ ~ Q ,  reducing 
substances in the stools were common both in ueaunent 
successes (61%) and in fàilures (87%). 
133 of the 143 eligible patients were tested for rotavirus, 
which was isolated fimm 47 (35%). There was no association 
between presence of mavirus and treament failure 
(OR 0.8,95% CI 0.3 to 2.0) or between presene of rotavirus 
and lactose intolerance (defined as stool reducing substances 
- 2.3%). 
> 0.5%) (OR 2.7,95% CI 0.9 to 7.7). 
Discussion 
Dilution of miik formula during diarrhoea has been 
advocated to r e d F  the risk of clinically significant milk 
intolerance (la& intolerance) in infants. Our srudy, the 
first conducted in developing countries and which included 
patients with severe diarrhoea and a significant proponion 
who were malnourished (48% of the patients had a 
weightlage z-smre below - 15), shows rhat roudne dilution 
of milk formula has no beneficial effect on the clinical course 
of illness and does not reduce the risk of treatment failure. In 
fact, total stool output, total number of stools passed, 
duration of diarrhoea, and r o d  inrake of ORS solution, * d 
water, and milk formula were similar in the two ueament 
groups. In addition, routine dilution of milk formula 
provided less energy and thus may conmbute to 
malnumtion, as suggested by our data. 
The rare of mannent failures (20%) leading to a change of 
diet is higher in our study than is usually reported for 
hospitalised infants with acute diarrhoea (5-10%).u This 
finding is probably a result of the sensitive definition of 
treatment failure that we used. Usually, only patients who 
cannot be rehydrated orally because of recurrent 
dehydration are regarded as treatment failures. If this 
definition had been applied, the rate of ueament failure 
would have been about 8% (12 treatment failures from 143 
patients), which is well within the usual range reported for 
this age group. In addition, in our study the rate oftreatment 
failures leading to a change of diet (20%) is only half of that 
reported by a UK study ( 4 2 % ) . 1 6  We believe that this is 
because we used only clinical indices to define trament 
failure (ie, reappearance of signs of dehydration at any dme 
after admission, and increased stool volume during 
ueament), whereas ueament failure in the British study 
was defined as continuing diarrhoea with the presence of 0.5 
to 2% reducing substances in stools. 
Although we found that treatment failures occurred 
almost enrirely among infants with faecal reducing 
substances, suggesting a role for lactose intolerance, it 
should be noted that 60% of the infants who had reducing 
substances in their stools were not treatment failures, even 
with the sensitive clhical criteria used in the study. This 
finding confirms other observations suggesting that 
presence of reducing substances in stools is not sufiicient as 
an indicator of clinically impoxtant lactase deficiency.23u 
Despite the high incidence of rotavirus infection (35%), we 
did not find any assodation between rotavirus infemion and 
presence of reducing substances in stools, as has been 
reported by 0thers.2~ 
Our findings support the conclusion that for infants aged 
under 6 months with diarrhoea whose only food is animal or 
formula milk, the miUr or formula normally given should be 
provided in full strength as soon as any dehydration has been 
corrected, mutine dilution of milk formula for such infants 
does not reduce the risk of treannent failure. However, the 
study does not provide any information on how to manage 
the minority of children who are regarded as treatment 
failures. The assodation of treament failure with f a d  
reducing substances supports efforrs to reduce dietary 
lactose, but this should not be at the expense of adequate 
nument intake. At least two approaches are possible: 
replacing milk temporarily with yoghurt where this is 
available and culturally acceptable, or replacing milk 
formula temporarily with a lactose-free formula. Although 
effecdve, the laner approach is obviously too costly for many 
families in the develdping world. 
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Cysticercosis as a major cause of epilepsy in Peru 
J.B.PIL(=HER G.HERRERA F . D m  M.ALVARADO E.MIRANDA 
H.H.GARm R.GILMAN M.MTINEZ V.C.W.TSANG 
AND THE CYSTlCERCOSIS WORKING GROUP INPERU (CWG) 
I 
In countries where cysticercosis is endemic, the 
proportion of epilepsy due to cysticercosis is not well 
documented. To investigate the association between 
cysticercosis and epilepsy, we used the enzyme- 
linked immunoelectrotransfer blot (EITB) assay 
to detect serum antibodies to Taenia solium in 
498 consecutive outpatients at a neurology clinic 
ir’l Lima, Peru. Every patient was classified 
as epileptic (n = 189) or non-epileptic 
(n = 309) after neurological, and where 
possible electroencephalographic, examination. A 
substantially higher proportion of epileptic than 
non-epileptic patients was seropositive in the EITB 
(22 [12%] YS 8 [3%], p<O-Ool). 19% of epileptic 
patients born outside Lima, 20% of those with 
late-onset epilepsy, and 29% of patients with both 
these characteristics wereseropositive. Thus, in Peru, 
cysticercosis is an important aetiological factor for 
epilepsy. 
Lancet 1 993; 341 : 1 97-200. 
J _.- 
introduction 
Neurocrjticercosis is common in rural afeas of 
developing munmes where fk-ranging pigs are raised. 
Clinically, the disorder can include many neurological 
sjmptoms, but epilepsy is the most “mon.L5 Rural areas 
of developing countries have higher rates of epilepsybJ and 
of Taenia dim inf&on8 than do urban areas and 
developed countries. Neurocysticerasis resulting h m  the 
+-: 
higher Tsolim infection rate may contribute to higher rates 
of epilepsy in these arcas? 
The proportion of epilepsy mes assodated with 
neurocysticercosis has not been well documented. 
Serological tests used to measure the prevalena of 
cystiicnmsis in epileptic populations were nor highly 
sensitive or ~peCific.~~J~ However, the enzyme-linked 
immunoelecauuansfer blot (EITB) assayuJ3 is 98% 
sensitive and 100% spec16c and can accurately diagnose 
T miim inféction. We used the E I D  assay to define the 
relation between epilepsy and cysticercosis in individuals 
attending a neurology outpatient clinic in Lima, Peru. 
Patients and methods 
The Instituto Nadonal de Ciencias Neurológicas is &e 
nnuological reference mm for Pau and mainly serves the lower 
and middle dsss sectors of the popuiation. New patients arc 
randomly assig~ed to one of six neurology outpanent dinia for 
evaluation. All new patients artending one such dinic (mnsultorio 
no 2) bmvcen April, 1990, and June, 1991, were enrolled in rhis 
study after they had given informed mnscn~ The study was 
approved by the ethical review boards of the Univasidad Peruana 
Cayetano Hadia and the Johns Hopkins University. 
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